UnitedHealth Group (NYSE:UNH) – Cantor Fitzgerald increased their FY2018 earnings per share estimates for UnitedHealth Group in a research note issued on Wednesday, April 18th. Cantor Fitzgerald analyst S. Halper now expects that the healthcare conglomerate will post earnings of $12.60 per share for the year, up from their prior estimate of $12.40. Cantor Fitzgerald currently has a “Overweight” rating and a $300.00 target price on the stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.30 EPS.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.91 by $0.13. The business had revenue of $55.19 billion during the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The company’s revenue was up 13.3% on a year-over-year basis. During the same period in the prior year, the business posted $2.37 earnings per share.
A number of other research firms have also weighed in on UNH. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target for the company in a research report on Saturday, January 20th. Piper Jaffray reissued a “buy” rating and issued a $270.00 target price on shares of UnitedHealth Group in a report on Wednesday. Sanford C. Bernstein set a $275.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Wednesday. Royal Bank of Canada reissued a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Finally, Oppenheimer boosted their target price on shares of UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $251.13.
UNH opened at $235.76 on Friday. The company has a market capitalization of $228,755.50, a price-to-earnings ratio of 23.41, a PEG ratio of 1.37 and a beta of 0.77. UnitedHealth Group has a 1-year low of $166.65 and a 1-year high of $250.79. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.71 and a quick ratio of 0.73.
In related news, Director William C. Ballard, Jr. sold 10,000 shares of the company’s stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now owns 76,637 shares of the company’s stock, valued at $18,881,824.06. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the sale, the insider now directly owns 173,229 shares in the company, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 76,817 shares of company stock worth $17,831,174. 0.89% of the stock is owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Aevitas Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $102,000. Exane Derivatives raised its stake in shares of UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after acquiring an additional 460 shares during the period. Pathstone Family Office LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $129,000. Trustcore Financial Services LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $133,000. Finally, Baystate Wealth Management LLC raised its stake in shares of UnitedHealth Group by 64.9% in the fourth quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock valued at $186,000 after acquiring an additional 300 shares during the period. 86.78% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Research Analysts Issue Forecasts for UnitedHealth Group’s FY2018 Earnings (UNH)” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://ledgergazette.com/2018/04/20/research-analysts-issue-forecasts-for-unitedhealth-groups-fy2018-earnings-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.